Insufficient research has been done on the clinical effects of face involvement in pediatric psoriasis patients. For a study, researchers sought to assess the relationship between face involvement and clinical characteristics, such as the severity of the disease, in children and adolescents with psoriasis.
Retrospective analysis and grouping of the clinical characteristics of psoriasis patients under the age of 20 who were diagnosed were done to determine whether or not facial involvement was evident at the time of presentation. In addition, between-group comparisons of demographic and clinical data were made.
A total of 110 individuals (62.9%) out of the 175 patients had psoriasis on their faces when they were diagnosed, in addition to having a higher body mass index (BMI) (P=.043) and psoriasis area and severity index (PASI) score (P<.001), the group with face involvement was also substantially younger at illness beginning (P=.032). When compared to the non-facial group, the severity of pruritus was substantially greater in the face group (P=.020). According to the PASI score and impacted body surface area, illness involvement of the nose was linked to the highest disease severity. In addition, the face group utilized considerably more treatment modalities than the non-facial group (P=.013). BMI (odds ratio (OR), 1.39; 95% CI, 1.07–1.80) and PASI score (OR, 1.45; 95% CI, 1.03–2.03) were independent predictors linked to facial psoriasis involvement.
In children and teenagers, facial involvement in psoriasis was linked to a more severe illness and more treatment options.